Optimal Current Management Of Takayasu's Disease Involving The Supra-Aortic Branches: Technical Details For Open Surgical Management And What Is The Role For Endo Treatment With Bare Or Covered Stents

The Present Status Of Buerger’s Disease: Does It Still Exist; How To Diagnose And Treat It

How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well

Medical Treatment Of Patients With Vascular Ehlers Danlos Syndrome: How Does Celiprolol Treatment Work And How Does It Help

Current Optimal Antiplatelet And Anticoagulation Treatment For Various Vascular Procedures In Various Vascular Beds: What Newer Drugs And DOACs Are Useful And What Is The Optimal Timing Of Treatment

Understanding The Barriers To Antiplatelet And Statin Adherence Following Vascular Interventions: What Should Be Done About It

Panel Discussion

Next Generation Antithrombotic Agents: What’s On The Horizon For Anticoagulant And Antithrombotic Drugs: How Will They Work And How Helpful Will They Be

Lowering LDL-C And Controlling Elevated Blood Pressure And Lipoprotein Little A [Lp(a)] Can Lower Cardiovascular Risk 80%: What To Do If Patients Can’t Tolerate A Statin Dose: Ezetimibe (Zetia), A PCSK9 Inhibitor, Inclisiran, Bempedoic Acid (Nexletol), Etc.

What Are The Best Medical Treatments After Carotid, Aortic And Lower Extremity Endovascular And Open Procedures

Value And Limitations Of Statins And Non-Statin Lipid Lowering Agents And Other Medical Treatments In Patients With Carotid Artery Stenosis: Should They Be The Same Or Different In Patients Undergoing Invasive Procedures

Panel Discussion